Return to Results

A Phase IIIb, randomized, double blind, parallel-group, multi-center study to assess the efficacy and safety of multiple 30-minute infusions of Conivaptan in subjects with euvolemic or hypervolemic hy

new search

Trial Conditions
  • Euvolemic or Hypervolemic Hyponatremia
What is the purpose of this trial?

To assess the safety and efficacy of the study drug, Conivaptan, given in 4 separate 30-minute infusions.

Date & Status

Recruiting

Eligibility

Adults over 18 years of age, qualifying sodium level between 115 and 130- other exclusion criteria apply.

Facilities
  • St. Elizabeth's Medical Center - Recruiting
For more information about this trial, contact

Robert W. Mackinnon, RN, CNN
robert.mackinnon@steward.org
Phone: 617-562-7835


Other Information

Sponsor: Astellas Pharma, US, Inc.
Phase: Phase 3
Trial ID: 00394
Volunteers:  Not Accepting Healthy Volunteers

new search

Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

Subscribe to our patient e-newsletter

Copyright © 2014 Steward Health Care
Connect Healthcare Panacea CMS Solutions